Nucletron BV Waardgelder 1 POBox 930 Veenendaal Netherlands There is a complaint regarding internal check cable guide mechanism failure for the Nucletron Flexitron brachytherapy afterloader system. Due to an obstruction during the check cable out drive, the internal guiding tube became displaced and the check cable became damaged. This issue could cause treatment interruption or in a very unlikely scenario, incorrect source positioning and radiation treatment errors. Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
There is a complaint regarding internal check cable guide mechanism failure for the Nucletron Flexitron brachytherapy afterloader system. Due to an obstruction during the check cable out drive, the internal guiding tube became displaced and the check cable became damaged. This issue could cause treatment interruption or in a very unlikely scenario, incorrect source positioning and radiation treatment errors.
Brand
Nucletron BV Waardgelder 1 POBox 930 Veenendaal Netherlands
Lot Codes / Batch Numbers
REF 136149A02, UDI: (01)08717213051126 (11)171127 (21)FT00340 (240)136149
Products Sold
REF 136149A02; UDI: (01)08717213051126 (11)171127 (21)FT00340 (240)136149
Nucletron BV Waardgelder 1 POBox 930 Veenendaal Netherlands is recalling There is a complaint regarding internal check cable guide mechanism failure for the Nucletron Flexit due to A component failure may lead to treatment interruption or incorrect source positioning.. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
A component failure may lead to treatment interruption or incorrect source positioning.
Recommended Action
Per FDA guidance
The recalling firm will send a Field Safety Notice 806-01-BTD-001 to all affected customers. The notice informs user of the specific product and version numbers affected by the issue, and any work arounds that can be used to avoid the issue. A copy of the Field Safety Notice is to be kept with the most current labeling and all personnel working with the product should be made aware of the content of the letter. Customers are instructed to complete and return the Field Safety Notice Acknowledgement form to their local Eleka representative as soon as possible and no longer than 30 days from receipt.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026